Skip to content
Clinical Trials – home
AustriaBack to Austria

Clinical trials in Kufstein – page 6

69 clinical trials in Kufstein, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Kufstein at a glance
69
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

69 trials in Kufstein

Open in trial search

Study of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Astrazeneca AB

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan
  • Sponsor:Daiichi Sankyo Inc.

Neoplasm malignant

Not recruiting

Study on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:NSABP Foundation Inc.

Study on Ribociclib and Drug Combination for Patients with Advanced HER2-Negative, Hormone Receptor Positive Breast Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Institut Für Frauengesundheit GmbH

Plasma cell myeloma

Not recruiting

Study on Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Low-Risk Multiple Myeloma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Universitaetsklinikum Schleswig-Holstein AöR

Plasma cell myeloma

Not recruiting

Study of Isatuximab with Lenalidomide and Dexamethasone for Elderly Patients (70+) with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:65+ years
  • Substances:Isatuximab
  • Sponsor:Arbeitsgemeinschaft Medikamentoese Tumortherapie gGmbH

Myopia

Not recruiting

Study on Low-Dose Atropine Sulfate Eye Drops for Controlling Progressive Myopia in Caucasian Children

Investigational
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Atropine Sulfate
  • Sponsor:Medical Center - University Of Freiburg

Long-Term Safety Study of Fenfluramine for Patients with Myoclonic Astatic Epilepsy (Doose Syndrome)

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Fenfluramine Hydrochloride
  • Sponsor:Universitaetsklinikum Schleswig-Holstein AöR

Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Ibrutinib
  • Sponsor:Klinikum Der Universitat Munchen AöR

Other cities in Austria

The busiest research cities in the country

All 48 cities in Austria

Clinical research in Kufstein

What the registry says about research in the country

01 Breast Cancer Research

Innovative studies focusing on hormone receptor-positive (HR+)/HER2-negative breast cancer treatments, evaluating new therapeutic approaches for improved patient outcomes.

  • Palbociclib combination therapy evaluation
  • Extended therapy with camizestrant
  • Endocrine-based treatments

These trials aim to enhance standard endocrine therapy effectiveness in early-stage breast cancer treatment.

02 Allergy Studies

Research investigating treatments for seasonal allergic rhinitis and rhinoconjunctivitis, specifically targeting birch pollen-induced allergies.

  • PQ Birch allergen efficacy
  • Seasonal allergy management
  • Rhinoconjunctivitis treatment

Clinical evaluations focus on developing effective interventions for seasonal allergy symptoms.

03 Multiple Myeloma Research

Studies examining innovative treatments for newly diagnosed multiple myeloma in elderly patients, focusing on combination therapies.

  • Isatuximab combination therapy
  • Lenalidomide-based treatments
  • Maintenance therapy approaches

Investigations aim to improve treatment outcomes for elderly patients through targeted combination therapies.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.